A natural inhibitor of c-Met that sensitizes head and neck cancer cells resistant to EGFR and PI3K co-targeting

被引：0
|
作者：
Anisuzzaman, Asm [1 ]
Hague, Abedul [2 ]
Butler, Brian [3 ]
Amin, Arm R. [3 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Marshall Univ, Huntington, WV USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-706
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
706
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Src-Met signaling confers apoptosis resistance to EGFR and PI3K co-targeting independently of AKT and ERK pathway activation in head and neck cancer
    Anisuzzaman, Abu S.
    Haque, Abedul
    Chen, Zhuo G.
    Shin, Dong M.
    Amin, A. R. M. Ruhul
    CANCER RESEARCH, 2020, 80 (16)
  • [2] Differential modulation of PI3K/Akt/mTOR activity by EGFR inhibitors: A rationale for co-targeting EGFR and PI3K in cisplatin-resistant HNSCC
    Liao, Jipei
    Yang, Zejia
    Abarzarzin, Shirin
    Cullen, Kevin J.
    Dan, Hancai
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (05): : 1126 - 1135
  • [3] Co-targeting the PI3K and androgen receptor signal pathways in castration resistant prostate cancer
    De Velasco, Marco A.
    Kura, Yurie
    Ando, Naomi
    Fukushima, Emiko
    Hatanaka, Yuji
    Yamamoto, Yutaka
    Shimizu, Nobutaka
    Yoshimura, Kazuhiro
    Nozawa, Masahiro
    Yoshikawa, Kazuhiro
    Nishio, Kazuto
    Uemura, Hirotsugu
    CANCER RESEARCH, 2014, 74 (19)
  • [4] Dual EGFR and PI3k/mTOR Targeting of Head and Neck Cancer in Combination With Radiation Therapy
    Quinn, T. J.
    Galoforo, S.
    Wilson, T. G.
    Ahmed, S.
    Wilson, G. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E614 - E615
  • [5] Co-Targeting the EGFR and PI3K/Akt Pathway to Overcome Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma: What about Autophagy?
    Zaryouh, Hannah
    Van Loenhout, Jinthe
    Peeters, Marc
    Vermorken, Jan Baptist
    Lardon, Filip
    Wouters, An
    CANCERS, 2022, 14 (24)
  • [6] Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC
    Moore, Gillian
    Lightner, Clara
    Elbai, Samira
    Brady, Lauren
    Nicholson, Siobhan
    Ryan, Ronan
    O'Sullivan, Katie E.
    O'Byrne, Kenneth J.
    Blanco-Aparicio, Carmen
    Cuffe, Sinead
    O'Neill, Michael
    Heavey, Susan
    Finn, Stephen P.
    Gately, Kathy
    CANCERS, 2021, 13 (09)
  • [7] Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC
    Heavey, Susan
    O'Byrne, Kenneth J.
    Gately, Kathy
    CANCER TREATMENT REVIEWS, 2014, 40 (03) : 445 - 456
  • [8] Targeting EGFR and PI3K pathways in ovarian cancer
    S Glaysher
    L M Bolton
    P Johnson
    N Atkey
    M Dyson
    C Torrance
    I A Cree
    British Journal of Cancer, 2013, 109 : 1786 - 1794
  • [9] TARGETING EGFR AND PI3K PATHWAYS IN OVARIAN CANCER
    Cree, A.
    Glaysher, M.
    Bolton, L.
    Johnson, P.
    Atkey, N.
    Torrance, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 27 - 27
  • [10] Targeting EGFR and PI3K pathways in ovarian cancer
    Glaysher, S.
    Bolton, L. M.
    Johnson, P.
    Atkey, N.
    Dyson, M.
    Torrance, C.
    Cree, I. A.
    BRITISH JOURNAL OF CANCER, 2013, 109 (07) : 1786 - 1794
12345